Literature DB >> 18396855

Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.

Clive L Yeates1, John F Batchelor, Edward C Capon, Neil J Cheesman, Mitch Fry, Alan T Hudson, Mary Pudney, Helen Trimming, James Woolven, José M Bueno, Jesús Chicharro, Esther Fernández, José M Fiandor, Domingo Gargallo-Viola, Federico Gómez de las Heras, Esperanza Herreros, María L León.   

Abstract

A series of diaryl ether substituted 4-pyridones have been identified as having potent antimalarial activity superior to that of chloroquine against Plasmodium falciparum in vitro and murine Plasmodium yoelii in vivo. These were derived from the anticoccidial drug clopidol through a systematic study of the effects of varying the side chain on activity. Relative to clopidol the most active compounds show >500-fold improvement in IC50 for inhibition of P. falciparum in vitro and about 100-fold improvement with respect to ED50 against P. yoelii in mice. These compounds have been shown elsewhere to act selectively by inhibition of mitochondrial electron transport at the cytochrome bc1 complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396855     DOI: 10.1021/jm0705760

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

1.  Tyrosine triad at the interface between the Rieske iron-sulfur protein, cytochrome c1 and cytochrome c2 in the bc1 complex of Rhodobacter capsulatus.

Authors:  John A Kyndt; John C Fitch; Robert E Berry; Matt C Stewart; Kevin Whitley; Terry E Meyer; F Ann Walker; Michael A Cusanovich
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 2.  Recent updates in the discovery and development of novel antimalarial drug candidates.

Authors:  John Okombo; Kelly Chibale
Journal:  Medchemcomm       Date:  2018-02-02       Impact factor: 3.597

3.  4(1H)-pyridone and 4(1H)-quinolone derivatives as antimalarials with erythrocytic, exoerythrocytic, and transmission blocking activities.

Authors:  Andrii Monastyrskyi; Dennis E Kyle; Roman Manetsch
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

4.  Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.

Authors:  Brioni R Moore; Madhu Page-Sharp; Jillian R Stoney; Kenneth F Ilett; Jeffrey D Jago; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

5.  Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum.

Authors:  Sandhya Kortagere; William J Welsh; Joanne M Morrisey; Thomas Daly; Ijeoma Ejigiri; Photini Sinnis; Akhil B Vaidya; Lawrence W Bergman
Journal:  J Chem Inf Model       Date:  2010-05-24       Impact factor: 4.956

6.  Metal-free arylation of ethyl acetoacetate with hypervalent diaryliodonium salts: an immediate access to diverse 3-aryl-4(1H)-quinolones.

Authors:  Andrii Monastyrskyi; Niranjan K Namelikonda; Roman Manetsch
Journal:  J Org Chem       Date:  2015-02-24       Impact factor: 4.354

7.  Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance.

Authors:  Louise M Hughes; Charlotte A Lanteri; Michael T O'Neil; Jacob D Johnson; Gordon W Gribble; Bernard L Trumpower
Journal:  Mol Biochem Parasitol       Date:  2011-01-18       Impact factor: 1.759

8.  Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies.

Authors:  Raghupathi Neelarapu; Jordany R Maignan; Cynthia L Lichorowic; Andrii Monastyrskyi; Tina S Mutka; Alexis N LaCrue; Lynn D Blake; Debora Casandra; Sherwin Mashkouri; Jeremy N Burrows; Paul A Willis; Dennis E Kyle; Roman Manetsch
Journal:  J Med Chem       Date:  2018-02-09       Impact factor: 7.446

Review 9.  New medicines to improve control and contribute to the eradication of malaria.

Authors:  Timothy N C Wells; Pedro L Alonso; Winston E Gutteridge
Journal:  Nat Rev Drug Discov       Date:  2009-10-16       Impact factor: 84.694

10.  Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues.

Authors:  Pei-Liang Zhao; Le Wang; Xiao-Lei Zhu; Xiaoqin Huang; Chang-Guo Zhan; Jia-Wei Wu; Guang-Fu Yang
Journal:  J Am Chem Soc       Date:  2010-01-13       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.